腹膜透析相关感染率与结局:PDOPPS研究结果
该前瞻性队列研究纳入7国209家中心的7051例腹膜透析患者,发现各国腹膜炎发生率差异明显,且部分中心实践(自动化腹膜透析使用比例高、置管时预防性抗生素、培训≥6天)与较低腹膜炎风险相关。
要点
- 各国腹膜炎率不同,泰国最高(0.40次/患者年),美国最低(0.26次/患者年)。
- 10%的中心腹膜炎率超过0.50次/患者年,中心间差异大。
- 提高自动化腹膜透析使用比例、置管时用抗生素、培训≥6天与较低腹膜炎风险相关。
核心结论
- 国际间腹膜炎风险存在重要差异,可能源于可修改的治疗实践,研究结果可为未来指南设定更低的可接受腹膜炎率上限提供参考。
研究设计与样本
- 观察性前瞻性队列研究,纳入7个国家(澳大利亚、新西兰、加拿大、日本、泰国、英国、美国)209家中心的7051例成人腹膜透析患者。
主要发现
- 共识别2272次腹膜炎发作,粗发生率为0.28次/患者年。
- 各国腹膜炎发生率(次/患者年):泰国0.40(95% CI 0.36-0.46),英国0.38(95% CI 0.32-0.46),澳大利亚/新西兰0.35(95% CI 0.30-0.40),加拿大0.29(95% CI 0.26-0.32),日本0.27(95% CI 0.25-0.30),美国0.26(95% CI 0.24-0.27)。
- 各国内部中心间腹膜炎率存在变异,10%的中心率超过0.50次/患者年。
- 除泰国外,各国腹膜炎微生物学相似;泰国革兰阴性菌感染和培养阴性腹膜炎更常见。
- 日本中心规模与腹膜炎风险正相关(每增加10例患者,RR 1.07,95% CI 1.04-1.09)。
临床怎么用
- 可考虑提高自动化腹膜透析使用比例、置管时预防性使用抗生素、确保腹膜透析培训时长至少6天,以降低腹膜炎风险。
局限性
- 存在抽样变异、选择偏倚(率估计)和残余混杂(关联分析)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Peritoneal dialysis (PD)-related peritonitis carries high morbidity for PD patients. Understanding the characteristics and risk factors for peritonitis can guide regional development of prevention strategies. We describe peritonitis rates and the associations of selected facility practices with peritonitis risk among countries participating in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). STUDY DESIGN: Observational prospective cohort study. SETTING & PARTICIPANTS: 7,051 adult PD patients in 209 facilities across 7 countries (Australia, New Zealand, Canada, Japan, Thailand, United Kingdom, United States). EXPOSURES: Facility characteristics (census count, facility age, nurse to patient ratio) and selected facility practices (use of automated PD, use of icodextrin or biocompatible PD solutions, antibiotic prophylaxis strategies, duration of PD training). OUTCOMES: Peritonitis rate (by country, overall and variation across facilities), microbiology patterns. ANALYTICAL APPROACH: Poisson rate estimation, proportional rate models adjusted for selected patient case-mix variables. RESULTS: 2,272 peritonitis episodes were identified in 7,051 patients (crude rate, 0.28 episodes/patient-year). Facility peritonitis rates were variable within each country and exceeded 0.50/patient-year in 10% of facilities. Overall peritonitis rates, in episodes per patient-year, were 0.40 (95% CI, 0.36-0.46) in Thailand, 0.38 (95% CI, 0.32-0.46) in the United Kingdom, 0.35 (95% CI, 0.30-0.40) in Australia/New Zealand, 0.29 (95% CI, 0.26-0.32) in Canada, 0.27 (95% CI, 0.25-0.30) in Japan, and 0.26 (95% CI, 0.24-0.27) in the United States. The microbiology of peritonitis was similar across countries, except in Thailand, where Gram-negative infections and culture-negative peritonitis were more common. Facility size was positively associated with risk for peritonitis in Japan (rate ratio [RR] per 10 patients, 1.07; 95% CI, 1.04-1.09). Lower peritonitis risk was observed in facilities that had higher automated PD use (RR per 10 percentage points greater, 0.95; 95% CI, 0.91-1.00), facilities that used antibiotics at catheter insertion (RR, 0.83; 95% CI, 0.69-0.99), and facilities with PD training duration of 6 or more (vs <6) days (RR, 0.81; 95% CI, 0.68-0.96). Lower peritonitis risk was seen in facilities that used topical exit-site mupirocin or aminoglycoside ointment, but this association did not achieve conventional levels of statistical significance (RR, 0.79; 95% CI, 0.62-1.01). LIMITATIONS: Sampling variation, selection bias (rate estimates), and residual confounding (associations). CONCLUSIONS: Important international differences exist in the risk for peritonitis that may result from varied and potentially modifiable treatment practices. These findings may inform future guidelines in potentially setting lower maximally acceptable peritonitis rates.
引用
- Perl J, Fuller DS, Bieber BA, et al. Peritoneal Dialysis-Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Am J Kidney Dis. 2020. PMID: 31932094. doi:10.1053/j.ajkd.2019.09.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。